US Patent Issued to ALCEDIAG, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE PARIS CITE on April 7 for "Nano-rheological biomarkers for early and improved follow-up of pathologies associated to RBC deformability alteration" (French Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,596,125, issued on April 7, was assigned to ALCEDIAG (Peynier, France), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris) and UNIVERSITE PARIS CITE (Paris).

"Nano-rheological biomarkers for early and improved follow-up of pathologies associated to RBC deformability alteration" was invented by Berengere Abou (Paris), Franck Molina (Les Matelles, France) and Thomas Podgorski (Allevard, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to a method to detect in a blood sample whether the red blood cells (RBCs) contained in said blood sample present or not an alteration of their deformability by using molecular...